BFS
Bradley Foster & Sargent Portfolio holdings
AUM
$6.39B
This Quarter Return
-16.37%
1 Year Return
+19.77%
3 Year Return
+71.83%
5 Year Return
+128.21%
10 Year Return
–
AUM
$2.5B
AUM Growth
+$2.5B
(-23%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
29.82%
Holding
374
New
18
Increased
92
Reduced
174
Closed
48
Top Buys
| 1 |
Stryker
SYK
|
$19.7M |
| 2 |
IQVIA
IQV
|
$10.9M |
| 3 |
Home Depot
HD
|
$9.23M |
| 4 |
Amazon
AMZN
|
$7.59M |
| 5 |
Comcast
CMCSA
|
$5.55M |
Top Sells
| 1 |
Union Pacific
UNP
|
$18.9M |
| 2 |
Boston Properties
BXP
|
$15.4M |
| 3 |
Microsoft
MSFT
|
$14.5M |
| 4 |
Fortive
FTV
|
$14.2M |
| 5 |
Walt Disney
DIS
|
$13.6M |
Sector Composition
| 1 | Healthcare | 19.89% |
| 2 | Technology | 19.3% |
| 3 | Financials | 12.28% |
| 4 | Industrials | 9.9% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ameriprise Financial
AMP
$48.5B
| $293K | 0.01% |
2,855
-60
| -2% | -$6.16K |
|
|
UN
277
DELISTED
Unilever NV New York Registry Shares
UN
| $293K | 0.01% |
5,998
+1,208
| +25% | +$59K |
|
278
Alcon
ALC
$39.5B
| $290K | 0.01% |
5,712
-2,536
| -31% | -$129K |
|
279
Edwards Lifesciences
EW
$47.8B
| $290K | 0.01% |
1,538
| – | – |
|
280
Corteva
CTVA
$50.4B
| $289K | 0.01% |
12,308
-2,077
| -14% | -$48.8K |
|
281
Financial Select Sector SPDR Fund
XLF
$54.1B
| $288K | 0.01% |
13,836
-100
| -0.7% | -$2.08K |
|
282
Cullen/Frost Bankers
CFR
$8.3B
| $287K | 0.01% |
5,150
| – | – |
|
|
283
Boston Properties
BXP
$11.5B
| $286K | 0.01% |
3,103
-167,377
| -98% | -$15.4M |
|
284
Quest Diagnostics
DGX
$20.3B
| $283K | 0.01% |
3,519
-500
| -12% | -$40.2K |
|
285
Prudential Financial
PRU
$38.6B
| $283K | 0.01% |
5,433
-9,248
| -63% | -$482K |
|
|
DNKN
286
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $282K | 0.01% |
5,309
-1,955
| -27% | -$104K |
|
287
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $279K | 0.01% |
6,900
+906
| +15% | +$36.6K |
|
288
GSK
GSK
$79.9B
| $277K | 0.01% |
7,299
-1,050
| -13% | -$39.8K |
|
289
Equinix
EQIX
$76.9B
| $270K | 0.01% |
432
| – | – |
|
290
SPDR S&P Dividend ETF
SDY
$20.6B
| $269K | 0.01% |
+3,374
| New | +$269K |
|
291
Elevance Health
ELV
$71.8B
| $265K | 0.01% |
1,167
-6
| -0.5% | -$1.36K |
|
292
Take-Two Interactive
TTWO
$43B
| $263K | 0.01% |
+2,220
| New | +$263K |
|
293
Dover
DOV
$24.5B
| $262K | 0.01% |
3,116
| – | – |
|
294
Synopsys
SNPS
$112B
| $258K | 0.01% |
2,000
| – | – |
|
|
CDK
295
DELISTED
CDK Global, Inc.
CDK
| $258K | 0.01% |
7,844
-142
| -2% | -$4.67K |
|
296
iShares Russell 1000 Value ETF
IWD
$63.5B
| $255K | 0.01% |
2,568
-597
| -19% | -$59.3K |
|
297
Cytosorbents Corp
CTSO
$59.2M
| $254K | 0.01% |
32,890
-299
| -0.9% | -$2.31K |
|
298
Align Technology
ALGN
$10.3B
| $237K | 0.01% |
1,365
| – | – |
|
299
Tapestry
TPR
$21.2B
| $233K | 0.01% |
18,000
| – | – |
|
300
Cognizant
CTSH
$35.3B
| $230K | 0.01% |
4,955
-781
| -14% | -$36.3K |
|